BiotechTube

PrEP-001

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Influenza A H3N2

Conditions

Influenza A H3N2

Trial Timeline

Sep 16, 2015 → Feb 1, 2016

NCT ID
NCT03220048

About PrEP-001

PrEP-001 is a phase 2 stage product being developed by hVIVO for Influenza A H3N2. The current trial status is completed. This product is registered under clinical trial identifier NCT03220048. Target conditions include Influenza A H3N2.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT03338556Phase 2Completed
NCT03220048Phase 2Completed

Competing Products

20 competing products in Influenza A H3N2

See all competitors
ProductCompanyStageHype Score
Influenza vaccine, split inactivatedComac MedicalPhase 1
25
VaccineComac MedicalPhase 3
69
CT-P27 90 mg/kg + CT-P27 45 mg/kg + PlaceboCelltrionPhase 2
52
CT-P27 + PlaceboCelltrionPhase 2
52
CAIV-TPfizerPhase 3
76
CS-8958 + CS-8958 + oseltamivir phosphateDaiichi SankyoPhase 3
77
Baloxavir Marboxil + Placebo to Baloxavir Marboxil + Oseltamivir + Placebo to OseltamivirShionogiPhase 3
77
Baloxavir Marboxil + Placebo to Baloxavir Marboxil + Oseltamivir + Placebo to OseltamivirShionogiPhase 3
77
fH1 2 ug + fH1 8 ug + DSP-0546LP 2.5 ug + DSP-0546LP 5 ug + DSP-0546LP 10 ug + PlaceboSumitomo PharmaPhase 1
33
Monovalent Influenza VaccineAstraZenecaApproved
85
Monovalent Influenza VaccineAstraZenecaApproved
85
Trivalent Influenza VaccineAstraZenecaApproved
85
AZD4117 + AZD5315AstraZenecaPhase 1/2
41
Trivalent Influenza VaccineAstraZenecaApproved
85
FluMist trivalent (2015-2016) + FluMist Quadrivalent (2015-2016) + FluMist Quadrivalent (2017-2018)AstraZenecaApproved
85
Trivalent Influenza Virus VaccineAstraZenecaApproved
85
Comparator: Modified Process Vaccine + Comparator: COMVAX™MerckPhase 3
77
Molnupiravir + Placebo molnupiravir + Placebo oseltamivir + Oseltamivir + Influenza A VirusMerckPhase 1
33
V512 + Comparator: Placebo to V512MerckPhase 1
33
Vaxelis + PedvaxHIBMerckApproved
85

Other Products from hVIVO

CC-42344 + PlaceboPhase 2
44
PrEP-001 + G-004Phase 2
44
PrEP-001Phase 2
44
MV-012-968Phase 2
44
SAB-176Phase 2
44